Page 8 - Harold Burstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harold burstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harold Burstein Today - Breaking & Trending Today

Are Natural Deodorants Better for You? - The New York Times

Much of the marketing suggests that they’re safer than more traditional underarm products, but that hype is not based on science. ....

New York , United States , San Diego , San Francisco , Nina Botto , Jennifer Chen , Julia Calderone , Harold Burstein , Arielle Nagler , Amy Borenstein , Fannie Sneed , Jack Gilbert , Justin Boudrow , Public Radio International , University Of California , Care Products Council , Harvard Medical School , New York Times , Fast Company , N Yu Grossman School Of Medicine , Dana Farber Cancer Institute , American Cancer Society , Harvard Medical , Grossman School , Personal Care Products Council , Scientific American ,

Pandemic leads doctors to rethink unnecessary treatment

COVID-19 is opening the door on a problem that has long vexed the medical community: the overtreatment and unnecessary treatment of patients. ....

United States , William Connell School , Dana Farber Cancer Institute , Harold Burstein , Allison Oakes , Krista Petruzziello , Heather Lyu , Susan Gennaro , Jill Wruble , Research Consortium For Health Care Value Assessment , Health Affairs , Veterans Affairs , Harvard Medical School , Research Consortium , Health Care Value , Johns Hopkins Medicine , Boston College , Health Wellness , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , ஹரோல்ட் பர்ஸ்டீன் , அல்லிசன் ஓக்ஸ் , ஆராய்ச்சி கூட்டமைப்பு க்கு ஆரோக்கியம் பராமரிப்பு மதிப்பு மதிப்பீடு , ஆரோக்கியம் வாழ்க்கைத்தொழில்கள் , வீரர்கள் வாழ்க்கைத்தொழில்கள் ,

Pandemic leads doctors to rethink unnecessary treatment

Pandemic leads doctors to rethink unnecessary treatment
Covid-19 is opening the door for researchers to address a problem that has vexed the medical community for decades: the overtreatment and unnecessary treatment of patients.
On one hand, the pandemic caused major health setbacks for non-covid patients who were forced to, or chose to, avoid tests and treatments for various illnesses. On the other hand, in cases in which no harm was done by delays or cancellations, medical experts can now reevaluate whether those procedures are truly necessary.
But never before, said researcher Allison Oakes, has there been such a large database to compare patients who received a particular test or treatment with those who did not. ....

United States , William Connell School , Dana Farber Cancer Institute , Harold Burstein , Allison Oakes , Krista Petruzziello , Heather Lyu , Susan Gennaro , Jill Wruble , Emily Henderson , Research Consortium For Health Care Value Assessment , Health Affairs , Veterans Affairs , Harvard Medical School , Research Consortium , Health Care Value , Johns Hopkins Medicine , Boston College , Breast Cancer , Health Care , ஒன்றுபட்டது மாநிலங்களில் , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , ஹரோல்ட் பர்ஸ்டீன் , அல்லிசன் ஓக்ஸ் , எமிலி ஹென்டர்சன் , ஆராய்ச்சி கூட்டமைப்பு க்கு ஆரோக்கியம் பராமரிப்பு மதிப்பு மதிப்பீடு ,

Covid-19 forces physician to rethink treatments that are overdone or unnecessary

Covid-19 forces physician to rethink treatments that are overdone or unnecessary
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

United States , William Connell School , Dana Farber Cancer Institute , Harold Burstein , Allison Oakes , Krista Petruzziello , Heather Lyu , Susan Gennaro , Jill Wruble , Research Consortium For Health Care Value Assessment , Health Affairs , Kaiser Health News , Veterans Affairs , Kaiser Family Foundation , Harvard Medical School , Research Consortium , Health Care Value , Johns Hopkins Medicine , Boston College , ஒன்றுபட்டது மாநிலங்களில் , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , ஹரோல்ட் பர்ஸ்டீன் , அல்லிசன் ஓக்ஸ் , ஆராய்ச்சி கூட்டமைப்பு க்கு ஆரோக்கியம் பராமரிப்பு மதிப்பு மதிப்பீடு , ஆரோக்கியம் வாழ்க்கைத்தொழில்கள் , கைசர் ஆரோக்கியம் செய்தி ,

Panel Tells FDA to Keep Atezolizumab Approval in TNBC

email article
An advisory panel recommended the FDA not revoke the accelerated approval for atezolizumab (Tecentriq) in combination with nab-paclitaxel (Abraxane) for treating metastatic, PD-L1-positive triple-negative breast cancer (TNBC).
In a 7-2 vote, the Oncologic Drugs Advisory Committee (ODAC) affirmed the accelerated approval, with members clearly conflicted over the decision.
This was a difficult decision in a very difficult disease to treat, said Harold Burstein, MD, PhD, of the Dana-Farber Cancer Institute in Boston, who voted yes on the proposition. I have spent decades caring for these patients, and we all wish we had fundamentally better options.
FDA initially granted atezolizumab, a PD-L1 immune checkpoint inhibitor, accelerated approval in 2019 in combination with nab-paclitaxel for patients with untreated metastatic or locally advanced unresectable TNBC whose tumors express PD-L1, based on findings from the IMpassion130 trial, which showe ....

Dana Farber Cancer Institute , United States , Baylor College Of Medicine , Philip Hoffman , Harold Burstein , Stephen Chui , Alberto Montero , Laleh Amiri Kordestani , Matthew Ellis , Stanley Lipkowitz , Genentech Group Medical Director , National Cancer Institute In Bethesda , Oncologic Drugs Advisory Committee , University Of Chicago , Division Of Oncology , Case Western Reserve University In Cleveland , Drug Evaluation , National Cancer Institute , Case Western Reserve University , Group Medical , Baylor College , Triple Negative Breast Cancer , Breast Cancer , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , ஒன்றுபட்டது மாநிலங்களில் , பேலர் கல்லூரி ஆஃப் மருந்து ,